Coherus BioSciences Net Worth 2013-2021 | CHRS
Interactive chart of historical net worth (market cap) for Coherus BioSciences (CHRS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Coherus BioSciences net worth as of October 15, 2021 is $1.3B.
||Medical - Biomedical and Genetics
Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients. Coherus Biosciences, Inc. is headquartered in Redwood City, California.